Corrigendum: Microfluidic-based human prostate-cancer-on-chip (Frontiers in Bioengineering and Biotechnology, (2024), 12, (1302223), 10.3389/fbioe.2024.1302223)

Linan Jiang, Hunain Khawaja, Shekha Tahsin, Tanjia A. Clarkson, Cindy K. Miranti, Yitshak Zohar

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the published article, there was an error in the Funding statement. The Funding statement was incorrectly written as: “The author(s) declare financial support was received for the research, authorship, and/or publication of this article. LJ, HK, ST, TC, CM, and YZ were supported by funding from NIH/NCI MPI R01 CA254200 as part of the Tissue Engineering Consortium and TACMASR by P30 CA023075 UACC support grant. TC acknowledges partial support by the NIH/NCI U54CA143924 for the Partnership of Native American Cancer Prevention (NACP).”

Original languageEnglish (US)
Article number1520130
JournalFrontiers in Bioengineering and Biotechnology
Volume12
DOIs
StatePublished - 2024

Keywords

  • cancer-associated fibroblasts (CAFs)
  • microfluidics
  • organ-on-chip
  • prostate cancer
  • prostate tumor invasion
  • stromal fibroblasts
  • tumor microenvironment

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Histology
  • Biomedical Engineering

Fingerprint

Dive into the research topics of 'Corrigendum: Microfluidic-based human prostate-cancer-on-chip (Frontiers in Bioengineering and Biotechnology, (2024), 12, (1302223), 10.3389/fbioe.2024.1302223)'. Together they form a unique fingerprint.

Cite this